About: MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.14 (+0.89%)
MAIA NYSE MAIA Biotechnology Inc.
MAIA Biotechnology Inc. share price
Atividade de preço de MAIA
Último preço
$ 1,110
Variação (24h)
-0,03 USD (2,63%)
Volume
473.53K
Volume (média 4 sem.)
-
Abertura
$ 1,11
Variação do dia
$ 1,08 - $ 1,15
Fechamento anterior
$ 1,14
Último negócio
20 Nov, 9:00 pm GMT+0
Atrasado
20 Nov, 9:00 pm GMT+0
MAIA price performance
Atrasado
20 Nov, 9:00 pm GMT+0
MAIA details
quote.marketSignals